You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
23 December 2020
The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...
15 December 2020
The US Food and Drug Administration (FDA) has authorised the first COVID-19 test system for OTC purchase.
20 November 2020
The US Food and Drug Administration (FDA) has authorised the first COVID-19 test that can be “fully self-administered and provide results at home”.
2 November 2020
The US Food and Drug Administration (FDA) has switched Arbor Pharmaceuticals’ Sklice treatment for head lice from prescription-only to OTC status.
22 October 2020
The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for...
7 September 2020
A bipartisan bill that would allow hemp-derived cannabidiol (CBD) products to be marketed legally as dietary supplements has been introduced in the US.
28 April 2020
In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...
21 April 2020
In response to the COVID-19 pandemic, France has warned people to stop taking certain food supplements if they have COVID-19, the UK has issued advice on the use of ibuprofen and COVID-19, and the US has authorised the first diagnostic test for COVID-19 with at-home sample collection.
2 April 2020
The US Food and Drug Administration (FDA) has asked manufacturers to withdraw all prescription and OTC medicines containing ranitidine from the market immediately.
20 March 2020
The World Health Organization (WHO) has responded to reports that taking ibuprofen could worsen symptoms of the COVID-19 coronavirus.